Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
Benzinga·06/26/2026 14:18:56
Listen to the news
U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Friday.
Shares of Apogee Enterprises Inc (NASDAQ:APOG) rose sharply after the company reported better-than-expected first-quarter financial results.
Adjusted diluted earnings came in at 57 cents per share, topping the analyst consensus estimate of 45 cents. Net sales totaled $342.7 million, ahead of the $333.8 million estimate.
Apogee Enterprises shares jumped 13.2% to $48.07 on Friday.
Here are some other big stocks recording gins in today’s session.
- FuelCell Energy Inc (NASDAQ:FCEL) shares jumped 17.6% to $23.11. Jefferies analyst Dushyant Ailani upgraded FuelCell Energy from Hold to Buy and raised the price target from $16 to $24.
- BitVentures Limited (NASDAQ:BVC) gained 14.1% to $10.09.
- ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) jumped 10.3% to $26.16 after the company announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the granting of a market authorization for DAYBU.
- Sellas Life Sciences Group Inc (NASDAQ:SLS) gained 10.2% to $11.60.
- Moderna Inc (NASDAQ:MRNA) gained 9.4% to $65.38.
- Xunlei Ltd (NASDAQ:XNET) rose 9% to $5.48. Xunlei announced a $20 million share buyback program beginning July 1.
- Pulse Biosciences Inc (NASDAQ:PLSE) jumped 8.8% to $29.92.
- Century Therapeutics Inc (NASDAQ:IPSC) gained 8.7% to $2.50.
- Cantor Equity Partners II Inc (NASDAQ:CEPT) jumped 8.3% to $10.99. Cantor Equity Partners II and Securitize expect to raise $400 million following business combination.
- ARS Pharmaceuticals Inc (NASDAQ:SPRY) gained 8.2% to $8.68. ARS Pharmaceuticals on Wednesday reaffirmed its expectation to achieve cash-flow breakeven in 2027, even as no additional commercial formulary decisions for its epinephrine nasal spray Neffy were secured during the July 1, 2026 coverage cycle.
- ServiceNow Inc (NYSE:NOW) rose 6.4% to $95.32.
- BlackBerry Ltd (NYSE:BB) rose 6.4% to $11.00. BlackBerry recently reported fiscal first-quarter revenue of $152.9 million, up 26% from a year earlier and ahead of analyst estimates.
- Eli Lilly And Co (NYSE:LLY) gained 6% to $1,195.89. Eli Lilly received EMA CHMP positive opinion for Jaypirca in chronic lymphocytic leukemia.
- Crocs Inc (NASDAQ:CROX) jumped 5.8% to $125.77. Piper Sandler analyst Anna Andreeva upgraded Crocs from Neutral to Overweight and raised the price target from $95 to $150.
- Kodiak Sciences Inc (NASDAQ:KOD) gained 5.3% to $35.88.
Photo via Shutterstock
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.